Email Us Here

Ace Therapeutics Launches Full-Scale Preclinical Hematology CRO Services with Expanded In Vivo Hematologic Disease Models

Ace Therapeutics announces its comprehensive suite of integrated preclinical hematology CRO services designed to accelerate the discovery and regulatory advancement of novel therapeutics for a broad spectrum of hematologic diseases.